Cubist Pharmaceuticals Inc. has recalled some vials of its infection treatment Cubicin after finding glass particles.
The Lexington, Mass., company said late Thursday that no problems have been reported so far. It is notifying customers by letter and phone about the voluntary recall.
Cubicin is a treatment for skin infections like MRSA and blood infections.
The recall involves about 180,000 vials of Cubicin. Company spokeswoman Julie DiCarlo said they expect that most of the product covered by the recall has already been used.
The company said a preliminary investigation shows that the problem stems from a manufacturing issue with one of the company's suppliers, and Cubist has suspended all manufacturing with that supplier until it is corrected. It did not identify the supplier.
Cubist said the recall involves four lots of the drug that were shipped between May 31, 2011 and March 18, 2013. They have expiration dates that range from Dec. 6, 2013 to Sept. 1, 2015.
The lot numbers are 950453F, 090203F, 201703F and 201653F.
Shares of Cubist Pharmaceuticals closed at $64.04 on Thursday and have climbed about 52 percent since closing 2012 at $42.05.